Arena Pharmaceuticals Inc (NASDAQ:ARNA)

4.49
Delayed Data
As of Apr 24
 +0.05 / +1.13%
Today’s Change
3.26
Today|||52-Week Range
7.22
+29.39%
Year-to-Date

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Arena Pharmaceuticals Inc have a median target of 6.25, with a high estimate of 9.00 and a low estimate of 4.00. The median estimate represents a +39.20% increase from the last price of 4.49.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Hold stock in Arena Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.13
Sales
$10.9M
Reporting Date
Apr 28

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 10.28%
 
 
 
 
 
 
Growthannually -91.07%
 
 
 
 
 
 

Sales

Growthquarterly 18.42%
 
 
 
 
 
 
Growthannually 28.23%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account